JP2024517807A5 - - Google Patents

Info

Publication number
JP2024517807A5
JP2024517807A5 JP2023567884A JP2023567884A JP2024517807A5 JP 2024517807 A5 JP2024517807 A5 JP 2024517807A5 JP 2023567884 A JP2023567884 A JP 2023567884A JP 2023567884 A JP2023567884 A JP 2023567884A JP 2024517807 A5 JP2024517807 A5 JP 2024517807A5
Authority
JP
Japan
Prior art keywords
alkyl
composition according
different
pharmaceutically acceptable
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023567884A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517807A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/027784 external-priority patent/WO2022235874A1/en
Publication of JP2024517807A publication Critical patent/JP2024517807A/ja
Publication of JP2024517807A5 publication Critical patent/JP2024517807A5/ja
Pending legal-status Critical Current

Links

JP2023567884A 2021-05-05 2022-05-05 ヌクレオチド及びヌクレオシド治療組成物、組合せ、並びにそれらに関連する使用 Pending JP2024517807A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163184609P 2021-05-05 2021-05-05
US63/184,609 2021-05-05
PCT/US2022/027784 WO2022235874A1 (en) 2021-05-05 2022-05-05 Nucleotide and nucleoside therapeutic compositions, combinations and uses related thereto

Publications (2)

Publication Number Publication Date
JP2024517807A JP2024517807A (ja) 2024-04-23
JP2024517807A5 true JP2024517807A5 (cg-RX-API-DMAC7.html) 2025-05-14

Family

ID=83932924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023567884A Pending JP2024517807A (ja) 2021-05-05 2022-05-05 ヌクレオチド及びヌクレオシド治療組成物、組合せ、並びにそれらに関連する使用

Country Status (6)

Country Link
US (1) US20250281519A1 (cg-RX-API-DMAC7.html)
EP (1) EP4333859A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024517807A (cg-RX-API-DMAC7.html)
CN (1) CN117881402A (cg-RX-API-DMAC7.html)
CA (1) CA3216679A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022235874A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116554249B (zh) * 2022-01-28 2025-03-18 北京恩泰伟医药科技有限公司 抗病毒化合物及其用途
CN116199730A (zh) * 2023-04-24 2023-06-02 南京颐媛生物医学研究院有限公司 4-硫代尿嘧啶核糖核苷磷酸酯化合物及其制备方法和应用
CN117567310A (zh) * 2023-11-28 2024-02-20 重庆智合生物医药有限公司 一种神经酰胺np1的合成方法
WO2026043895A1 (en) * 2024-08-19 2026-02-26 Altesa BioSciences, Inc. Method of treating respiratory conditions in chronic obstructive pulmonary disease patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR213700A0 (en) * 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
CN102046621B (zh) * 2008-05-27 2014-11-12 生物区科学管理控股有限公司 抗病毒盐
WO2011160191A1 (en) * 2010-06-25 2011-12-29 Biota Scientific Management Pty Ltd Compound for the treatment of enteroviruses
TW201542581A (zh) * 2013-09-11 2015-11-16 艾默理大學 核苷酸與核苷治療組成物及其相關用途
WO2016145142A1 (en) * 2015-03-10 2016-09-15 Emory University Nucleotide and nucleoside therapeutics compositions and uses related thereto
KR20260028884A (ko) * 2018-03-07 2026-03-04 에모리 유니버시티 4'-할로겐 함유 뉴클레오티드 및 뉴클레오시드 치료 조성물 및 이와 관련된 용도

Similar Documents

Publication Publication Date Title
RU2486181C2 (ru) Пиримидилциклопентаны как ингибиторы акт-протеинкиназ
JP2024543976A5 (cg-RX-API-DMAC7.html)
JP2024520481A5 (cg-RX-API-DMAC7.html)
RU2475478C2 (ru) Соединения для лечения пролиферативных расстройств
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
JP2019509276A5 (cg-RX-API-DMAC7.html)
RU2009102252A (ru) Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с
JP2017512191A5 (cg-RX-API-DMAC7.html)
JP2010533160A5 (cg-RX-API-DMAC7.html)
JP2013545816A5 (cg-RX-API-DMAC7.html)
CO5390079A1 (es) Compuestos heterociclicos novedosos que tienen actividades hipolipidemicas, hipocolesterolicas, proceso para su preparacion y composiciones farmaceuticas que los contienen y su uso en medicina
JP2014521688A5 (cg-RX-API-DMAC7.html)
JP2013545818A5 (cg-RX-API-DMAC7.html)
JP2013056886A5 (cg-RX-API-DMAC7.html)
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
JP2013544812A5 (cg-RX-API-DMAC7.html)
RU2009132512A (ru) Аналоги 2-5а и способы их применения
RU2003137561A (ru) 4-замещенные нуклеозиды
EA201491180A1 (ru) 4'-азидо,3'-фторзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гепатита с
JP2014532716A5 (cg-RX-API-DMAC7.html)
JP2018522861A5 (cg-RX-API-DMAC7.html)
JP2021523108A5 (cg-RX-API-DMAC7.html)
RU2010145463A (ru) Производные замещенного 2-фенилпиридина
IL310611A (en) Substituted arylmethylureas and heteroarylmethylureas, analogues thereof, and methods using same
RU2006134022A (ru) Производные индазола и содержащие их фармацевтические композиции